Trial intelligence / Profile preview

Preemptive Volume Loading to Prevent Hypotension During Anesthesia Induction

NCT01594021Phase 4Terminated

Sponsor
Hôpital Foch
Start
Jul 2012
Primary completion
Jun 2014
Modality
Recombinant Proteins and Enzymes, Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of gelatin in arterial hypotension (2 arms), sponsored by Hôpital Foch. Primary endpoint: Hypotension at 30 minutes. Started Jul 2012; status: terminated.

02

Drugs

gelatin
03

Conditions

arterial hypotension

Beyond the preview

Go deeper on NCT01594021.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01594021.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call